Dr Karola Prinz, MD | |
301 Godwin Ave, Midland Park, NJ 07432-1544 | |
(201) 444-4526 | |
(201) 301-1313 |
Full Name | Dr Karola Prinz |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 41 Years |
Location | 301 Godwin Ave, Midland Park, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437115193 | NPI | - | NPPES |
757208 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MA057058 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Valley Home Care Inc. | Paramus, NJ | Home health agency |
Valley Hospital | Ridgewood, NJ | Hospital |
Hackensack University Medical Center | Hackensack, NJ | Hospital |
St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Valley Physician Services Pc | 3577857333 | 402 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) joined with The Advertising Council today to launch a national public service campaign designed to raise awareness among middle-aged men about the importance of preventive medical testing.
The current issue of the Lancet is dedicated to HIV/AIDS, a theme meant to coincide with the sixth International AIDS Society (IAS) conference on HIV pathogenesis, treatment and prevention taking place in Rome, Italy, July 17-20, according to a Lancet article.
› Verified 4 days ago
Entity Name | William K Lee Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508891003 PECOS PAC ID: 5294760161 Enrollment ID: O20050929000093 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) joined with The Advertising Council today to launch a national public service campaign designed to raise awareness among middle-aged men about the importance of preventive medical testing.
The current issue of the Lancet is dedicated to HIV/AIDS, a theme meant to coincide with the sixth International AIDS Society (IAS) conference on HIV pathogenesis, treatment and prevention taking place in Rome, Italy, July 17-20, according to a Lancet article.
› Verified 4 days ago
Entity Name | Valley Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467815928 PECOS PAC ID: 3577857333 Enrollment ID: O20160802002824 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) joined with The Advertising Council today to launch a national public service campaign designed to raise awareness among middle-aged men about the importance of preventive medical testing.
The current issue of the Lancet is dedicated to HIV/AIDS, a theme meant to coincide with the sixth International AIDS Society (IAS) conference on HIV pathogenesis, treatment and prevention taking place in Rome, Italy, July 17-20, according to a Lancet article.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Karola Prinz, MD 301 Godwin Ave, Midland Park, NJ 07432 Ph: (201) 444-4526 | Dr Karola Prinz, MD 301 Godwin Ave, Midland Park, NJ 07432-1544 Ph: (201) 444-4526 |
News Archive
The cholesterol-lowering drug pravastatin is highly effective in lowering the risk of heart attack and other cardiovascular events in patients with diabetes and chronic kidney disease (CKD), reports a study in the December Journal of the American Society of Nephrology.
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers and their sensitivity to potential therapeutic agents.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) joined with The Advertising Council today to launch a national public service campaign designed to raise awareness among middle-aged men about the importance of preventive medical testing.
The current issue of the Lancet is dedicated to HIV/AIDS, a theme meant to coincide with the sixth International AIDS Society (IAS) conference on HIV pathogenesis, treatment and prevention taking place in Rome, Italy, July 17-20, according to a Lancet article.
› Verified 4 days ago
Dr. Ladan H Bahrampour, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 Godwin Ave, Midland Park, NJ 07432 Phone: 201-444-5992 | |
Dr. Rima Kopelman, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 301 Godwin Ave, Midland Park, NJ 07432 Phone: 201-444-4526 Fax: 201-301-1313 | |
Dr. Marc Sanford Melamed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 44 Godwin Ave Ste 201, Midland Park, NJ 07432 Phone: 201-689-7755 Fax: 201-689-0387 | |
Rupesh M Vakil, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 Godwin Ave, Suite 201, Midland Park, NJ 07432 Phone: 201-689-7755 Fax: 201-689-0521 | |
Dr. Sally E Cohen, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 Godwin Ave, Midland Park, NJ 07432 Phone: 201-444-4526 Fax: 201-689-0438 | |
Evan Howard Leibowitz, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 301 Godwin Ave, Midland Park, NJ 07432 Phone: 201-444-4526 Fax: 201-301-1313 |